Cleerly
See Cleerly. Act early.
New York, United States · Founded 2017 · $383.0M raised
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2017
- Business Model
- SaaS
- Website
- cleerlyhealth.com
- Total Funding
- $383.0M
- Last Round
- $106.0M Series CDec 2024
- Rounds
- 4
About
Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. It measures plaque volume, composition, evaluates stenosis severity, and determines ischemia presence.
Summary
Cleerly is an Artificial Intelligence company based in New York, United States, founded in 2017. It has raised $383.0M in total across 4 rounds, most recently a $106.0M Series C round in Dec 2024. Investors include Vensana Capital, Insight Partners and LRVHealth.
Tech & App Stack
11 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...